Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (16610)	2/14/2004 1:30:43 AM
From: Bluegreen	Respond to of 17367

Come on Cacaito, you and I both know if YOU have Psoriasis there is no such thing as MILD psoriasis. Look at the surveys of people with Psoriasis ANY Psoriasis!!!!! They are COMPLETELY unhappy with current therapies. EVERY expert says that Biologics will TRANSFORM the Psoriasis market......they are not just talking about treating SEVERE Psoriasis. They are talking about TRANSFORMING the ENTIRE spectrum of Psoriasis AND utilizing ALL indicated Biologics. You are VERY wrong about resistance to biologicals. You are CONFUSING different response rates with subsets of patients. One can ALWAYS get around "resistance" by rotation and combination just like you do with antihistamines or oral anti-inflammatory agents. Once again think SUBSETS of patients, rotation, combination AND utilizing ALL indicated Biologicals including your beloved Amevive. In my opinion Psoriasis treatment with Biologicals will be 3 to 5 Billion dollar market in USA alone by the end of this decade.

To: Cacaito who wrote (16610)	2/14/2004 1:39:51 AM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

BTW, Cacaito, think ACNE!!!! MILD ACNE!!!!! Some say around 2 BILLION dollar market in the USA!!!!! AMAZING how little Xoma got the cost down enough to treat MILD ACNE if approved. AND remember Xoma is FLUSH with CASH!